P/E ratio for Teva Pharmaceutical Industries (TEVA)
P/E ratio as of May 2024 (TTM): -8.55
According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.545. At the end of 2022 the company had a P/E ratio of -4.30.
P/E ratio history for Teva Pharmaceutical Industries from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -4.30 | -120.41% |
| 2021 | 21.1 | -895.1% |
| 2020 | -2.65 | -75.11% |
| 2019 | -10.7 | 60.27% |
| 2018 | -6.65 | 470.31% |
| 2017 | -1.17 | -100.23% |
| 2016 | 518 | 1351.64% |
| 2015 | 35.7 | 122.07% |
| 2014 | 16.1 | -39.88% |
| 2013 | 26.7 | 61.01% |
| 2012 | 16.6 | 27.88% |
| 2011 | 13.0 | -7.39% |
| 2010 | 14.0 | -42.88% |
| 2009 | 24.5 | -53.9% |
| 2008 | 53.2 | 190.79% |
| 2007 | 18.3 | -62.32% |
| 2006 | 48.6 | 95.33% |
| 2005 | 24.9 | -56.71% |
| 2004 | 57.4 | 160.23% |
| 2003 | 22.1 | -11.42% |
| 2002 | 24.9 | -15.12% |
| 2001 | 29.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 27.6 | -423.27% | 🇨🇭 Switzerland |
 Pfizer PFE | 15.3 | -278.56% | 🇺🇸 USA |
 Sanofi SNY | 15.6 | -282.15% | 🇫🇷 France |
 Merck MRK | 70.6 | -926.53% | 🇺🇸 USA |
 AstraZeneca AZN | 38.8 | -554.20% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 13.0 | -252.64% | 🇬🇧 UK |
 Dr. Reddy's RDY | 18.8 | -319.71% | 🇮🇳 India |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.